Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes

Results show increased long-term risk for osteoporosis, gout and osteomalacia in one study; improved postoperative outcomes for common orthopaedic procedures in another NEW ORLEANS, March 2, 2026 /PRNewswire/ -- The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including...